{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T07:08:26Z","timestamp":1765177706464},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jbspin.2015.02.011","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T22:28:04Z","timestamp":1436826484000},"page":"432-436","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Body Mass Index and response to rituximab in rheumatoid arthritis"],"prefix":"10.1016","volume":"82","author":[{"given":"S\u00e9bastien","family":"Ottaviani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana\u00efs","family":"Gardette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Tubach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghislaine","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Dieud\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.02.011_bib0180","series-title":"Obesity: preventing and managing the global epidemic","author":"WHO","year":"2000"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0185","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0190","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrrheum.2009.232","article-title":"Rheumatoid arthritis: the multifaceted role of adiponectin in inflammatory joint disease","volume":"5","author":"Muller-Ladner","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/rheumatology\/keq266","article-title":"Obesity in rheumatoid arthritis","volume":"50","author":"Stavropoulos-Kalinoglou","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0200","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0205","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/rheumatology\/kel124","article-title":"Obesity and cardiovascular risk factors in rheumatoid arthritis","volume":"45","author":"Armstrong","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0210","first-page":"525","article-title":"Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis","volume":"5","author":"Voigt","year":"1994","journal-title":"Epidemiology"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0215","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/art.1780401106","article-title":"Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England","volume":"40","author":"Symmons","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0220","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/art.23033","article-title":"Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index","volume":"56","author":"Westhoff","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.2007.078832","article-title":"A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis","volume":"67","author":"van der Helm-van Mil","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0230","first-page":"2350","article-title":"Relation between body mass index and radiological progression in patients with rheumatoid arthritis","volume":"30","author":"Kaufmann","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0235","first-page":"1505","article-title":"Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor","volume":"19","author":"Roubenoff","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0240","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.30136","article-title":"Body mass index and clinical response to infliximab in rheumatoid arthritis","volume":"63","author":"Klaasen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0245","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/acr.21768","article-title":"Obesity and reduction of the response rate to anti-tumor necrosis factor alpha in rheumatoid arthritis: an approach to a personalized medicine","volume":"65","author":"Gremese","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0250","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/acr.21978","article-title":"Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients","volume":"65","author":"Heimans","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/acr.21711","article-title":"Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis","volume":"65","author":"di Minno","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0260","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/annrheumdis-2013-204448","article-title":"Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis","volume":"74","author":"Eder","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0265","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar3841","article-title":"Body mass index influences the response to infliximab in ankylosing spondylitis","volume":"14","author":"Ottaviani","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0270","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/rheumatology\/ket433","article-title":"Body weight, gender and response to TNF-alpha blockers in axial spondyloarthritis","volume":"53","author":"Gremese","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0275","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/art.30233","article-title":"B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study","volume":"63","author":"Sellam","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jbspin.2011.05.002","article-title":"Efficacy of rituximab in the treatment of rheumatoid arthritis. Influence of serologic status, coprescription of methotrexate and prior TNF-alpha inhibitors exposure","volume":"79","author":"Solau-Gervais","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0285","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3899\/jrheum.110610","article-title":"Effectiveness of rituximab in patients with rheumatoid arthritis: observational study from the British Society for Rheumatology Biologics Register","volume":"39","author":"Soliman","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0290","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jbspin.2014.06.001","article-title":"High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis","volume":"81","author":"Gardette","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0295","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0300","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0305","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2010.144998","article-title":"Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"70","author":"Buch","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0310","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","article-title":"Validation of rheumatoid arthritis improvement criteria that include simplified joint counts","volume":"41","author":"van Gestel","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/keq230","article-title":"Predicting arthritis outcomes\u00a0\u2013\u00a0what can be learned from the Leiden Early Arthritis Clinic?","volume":"50","author":"de Rooy","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0325","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pmn.2011.06.002","article-title":"Fibromyalgia's key symptoms in normal-weight, overweight, and obese female patients","volume":"14","author":"Aparicio","year":"2013","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0330","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/art.30291","article-title":"Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases?","volume":"63","author":"Neumann","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0335","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0340","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1186\/ar3900","article-title":"Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis","volume":"14","author":"Stavropoulos-Kalinoglou","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0345","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM200401153500324","article-title":"Rituximab therapy for the type B syndrome of severe insulin resistance","volume":"350","author":"Coll","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2015.02.011_bib0350","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ejh.12285","article-title":"Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"93","author":"Camus","year":"2014","journal-title":"Eur J Haematol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15001189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15001189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T19:56:13Z","timestamp":1537473373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X15001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1297319X15001189"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.02.011","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Body Mass Index and response to rituximab in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}